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Abstract
We present a review on the application of silver-
containing compounds that have been incorporated in
the surfaces of a large variety of medical devices
including vascular, urinary, and peritoneal catheters,
endotracheal tubes, sutures, and fracture fixation
devices, as well as other materials such as plastics in
kitchen appliances and fabrics. We found renewed and
rising interest in silver-containing materials due to their
antimicrobial, including antiviral and antifungal,
properties, their good toxicology and environmental
record. Silver-containing compounds could be used
against bacterial strains that are known to be resistant
to antibiotics. More research is necessary to determine
safe levels and particle-size of silver for use in humans.
Keywords: silver; antimicrobial, antibacterial.
Introduction
The search for new antimicrobial agents is an
ongoing process. The rising numbers of antibiotic
resistant bacterial strains (Rosenblatt-Farrell 2009),
immunodeficiency, and an increase in chronic diseases
such as diabetes that decrease the natural healing
capability of the organism drive the search.
Silver has a long history of use by humans. In
ancient times it was used to purify and store water.
Alexander the Great (335 BC) drank water from silver-
containing vessels (Russel et al. 1994, White 2002).
Silver was used aboard the Apollo, the MIR space
station, and NASA space shuttles for water purification
(Conrand et al. 1999). In 1800, 2% silver nitrate was
used for treatment of ophthalmia neonatorum in
newborns (Klasen 2000). Since the 1960’s, silver
sulfadiazine has been used as a topical antibacterial
(Fox 1968). The emergence of resistant strains of
bacteria, such as MRSA, provoked the search for new
antimicrobials. There is an increasing interest in
silver-containing materials due to their antimicrobial
properties in applications such as pharmacology,
medicine, the food industry and the healthcare
environment (Petica et al. 2008).
Advances have been made in the last decade in
medical grade silver technology, from the synthesis of
safer and bioavailable silver compounds to new
delivery techniques and new environmentally friendly
“green” silver containing disinfectants.
The purpose of this literature review is to discuss
the use of silver-containing compounds in medicine
and beyond.
Why does silver work?
Russel et al (1994) found that silver binds to
bacterial DNA and affects cell replication. By
interfering with replication, silver ions reduce the
number of the bacteria, eventually killing the entire
population (Russel et al. 1994).
According to the Kong and Jang (2008), there are
several possible explanations of bactericidal properties
of silver: 1) silver ions inhibit ATP synthesis via
binding to the enzyme associated with ATP generation
in the cell, 2) silver ions enter the cell, bind to its DNA,
leading to DNA denaturation, 3) silver ions block the
respiratory chain in the cytochrome oxidase and
NADH-succinate dehydrogenase region, inhibiting
ATP generation by the microorganism.
Petica et al (2008) believe that the mechanism of
the antibacterial effects of the silver ions (Ag+)
involves their absorption and accumulation by bacterial
cells and shrinkage of the cytoplasmic membrane and
its detachment from the cell wall. Due to the
infiltration of the cell by Ag+ ions, DNA molecules
become condensed and incapable of replication.
It has been reported that the mode of action of
silver nanoparticles is similar to that of silver ions.
However, the effective bactericidal concentration of
silver nanoparticles is at a nanomolar level as
compared to a micromolar level for silver ions (Kong
and Jang 2007).
Current Applications
Use of medical devices, such as central venous or
urinary catheters, is associated with infection risks due
50
Journal of the Arkansas Academy of Science, Vol. 64 [2010], Art. 13
Published by Arkansas Academy of Science, 2010
Search for the Next “Silver Bullet”: A Review of Literature
Journal of the Arkansas Academy of Science, Vol. 64, 2010
51
to the inevitable colonization of the catheter surface by
bacteria. With a goal to reduce infection, silver based
molecules of different size and concentrations have
been incorporated into the surfaces of a large variety of
medical devices including bladder catheters, central
venous catheters and peritoneal catheters.
Catheters
A study by Jansen and colleagues (1994) evaluated
the in vitro biocompatibility and the antimicrobial
activity of silver-coated polyurethane catheters. The
catheters were designed to be used as an antimicrobial
material and to prevent the bacterial colonization
associated with use of a catheter. The antimicrobial
activity of the catheters was tested using
Staphylococcus epidermidis, Escherichia coli and
Pseudomonas aeruginosa. Catheters coated with silver
demonstrated antimicrobial capability and performed
well in cell toxicity, blood compatibility, and acute
toxicity tests in mice. For all test strains, a reduction in
the number of adherent cells to the silver-coated
catheters was observed, which was more pronounced
after an adherence time of 24 h. In a case of S.
epidermidis (108 cfu/ml) % reduction of adherence in 3
h was 82.7% and 90% in 24 h, 90% in 3 h; 83.7% in
24 h for E. coli and 99.9 % in 3 and 24 h for P.
aeruginosa. With an inoculum of 105 cfu/ml, S.
epidermidis demonstrated 94.6 % reduction of
adherence in 3 h and 80.0 in 24 h, E. coli - 93.3% in 3
h and 99.1 % in 24 h, and P. aeuginosa – 99.9% in 3 h
and 24 h (Jansen et al. 1994).
According to research from the University of
Michigan Health System, 5% of hospitalized patients
that undergo urinary catheterization develop
bacteriuria. Proper management of the drainage
system, including use of the antimicrobial agents and
rigorous cleansing, was emphasized, but seem to have
only a small benefit. Saint and Lipsky (1999) analyzing
results of 8 randomized trials involved silver-coated
urinary catheters found, that silver alloy catheters were
significantly better in prevention of bacterial infections
than noncoated control catheters and it would be
reasonable to consider using silver alloy catheters in
hospitalized patients (Saint and Lipsky 1999).
Johnson and associates (2006) have also concluded
that “antimicrobial urinary catheters can prevent
bacteriuria in hospitalized patients”, but the effect
depends on the characteristics of the antimicrobial
coating, such as the size of the silver particles (Johnson
et al. 2006).
Loertzer and colleagues (2006) found evidence that
the use of catheters coated with silver reduced the risk
of infection in kidney transplant recipients. There is an
increased risk of microbial infection in transplant
patients due to immunosuppression therapy (Zand
2005). The main cause of the catheter-related
infections is microbial colonization of the central
venous catheters. Catheters were analyzed
microbiologically. Catheters coated with silver
demonstrated a significant reduction in associated
infections of the blood stream, as well as increased
protection against bacteria and fungi during the entire
time of catheterization (Loertzer et al. 2006).
Endotracheal tubes (ETTs).
Endotracheal tubes are often used in the
management of a patient’s airway. Bacterial biofilms
may form on the surface of the endotracheal tubes in
and around the place of the insertion and may increase
risk of the pneumonia being developed by the patient.
Berra et al (2008) developed and tested ETTs
coated with silver sulfadiazine (SSD). In the in- vitro
study SSD-ETTs demonstrated bactericidal properties
against P. aeruginosa, preventing biofilm formation on
ETT lumen in 6, 24 and 72 h, whereas standard ETT
(St-ETT) showed heavy P.aeruginosa growth and
biofilm formation (p<0.01). In 24-h study of young
female Dorset sheep, 4 sheep received SDD-ETT and
showed no bacterial growth in ETT, while heavy
colonization was found in sheep received St-ETT
(p<0.01) (Berra et al. 2008).
Silver-coated megaprosthesis
Despite the use of antibiotic prophylaxis, infection
rates associated with implantation of prostheses remain
high. Gosheger et al (2004) evaluated the antimicrobial
efficacy and side effects of the silver coated
megaprosthesis. 15 rabbits received titanium
endoprostheses and 15 – silver coated one. Both groups
were infected with Staphylococcus aureus (Strain
number A 22616-5) isolated from bone specimen of a
34 years-old female with osteomyelitis. After 90 days
of observation, group of rabbits with silver coated
endoprosthesis demonstrated significantly lower
inflammation sigs (p<0.005) including C-reactive-
protein and neutrophilic leukocytes measurements in
comparison with the group with titanium
endoprosthesis. Infection rates were also significantly
lower in the group with silver endoprosthesis (7%
versus 47% ). The silver concentration in the blood and
organs of the rabbits were elevated (mean 1.883 and
0.798-86.002 ppb respectively), but did not cause
pathological changes in the organs including brain,
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heart, kidney and reproductive organs (Gosheger et al.
2004).
Dental care
Scientists are in agreement that dental caries
caused by Streptococcus mutans is a worldwide, public
health concern, especially in patients whose immune
system has been compromised.
Hernandez-Sierra et al (2008) used nanoparticles
of silver, zinc oxide, and gold of an average size of 25
nm, 125 nm and 80 nm respectively to demonstrated
bacteriostatic and bactericidal effects on S. mutans.
Findings showed that nanoparticles of silver, as
compared with those of gold and zinc oxide, required a
lower concentration (MIC on average
4.86±2.71µg/mL) to inhibit development of the S.
mutans strains compare to the zinc oxide (MIC on
average 500±306.18µg/mL) and gold (MIC on average
197 µg/mL) leading to consideration that silver
particles may be most effective for controlling S.
mutans and therefore caries (Hernandez-Sierra et al.
2008).
Three sizes of silver nanoparticles were used to
find minimum inhibitory concentration (MIC) for
Streptococcus mutans in the study by Espinosa-
Cristobal and associates (2009). Nanoparticles with the
lowest MIC was 8.4 nm in diameter, followed by 16.1
and 98 nm, suggesting that antibacterial property of
silver nanoparticles possibly depend on the size of the
particles (Espinosa-Cristobal et al. 2009).
Eye care
Antimicrobial medications that are traditionally
used on the ocular surface are effective, but they are
rapidly cleared through the tear ducts, reducing contact
time and drug effectiveness.
Contact lenses containing silver nanoparticles as an
antimicrobial measure have been studied. Santoro et al.
(2007) investigated silver nanoparticles as a source of
silver ions against contact lens-associated bacterium,
Pseudomonas aeruginosa strain PA01. BBL™
Prompt™ tube containing 1.5 ×108 CFU/ml P.
aeruginosa was inoculated to 1 ×105 CFU/ml in
Erlenmeyer flasks containing 20 ml media with silver
nanoparticles. Also, solutions of 20 ml media
containing various concentrations (2, 4, 6, 10 µM) of
control silver nitrate were inoculated to 1 ×105 CFU/ml
of bacteria. Flasks were incubated overnight at 37 °C
while shaking at 200 rpm. Minimal bactericidal effects
were observed for several nanoparticles suspensions
(with maximum of 2.6 µM silver ion concentration),
which believed to be due to that silver particles
themselves at this concentration and size ranging from
20 to 60 nm are not microcidal under conditions tested
and substantial increase in silver particle loading in the
lens in the future experiments will allow to produce
desirable bactericidal effect (Santoro et al. 2007).
Silver-antibiotic combination
Shahverdi et al (2007) demonstrated that
combining penicillin G, amoxicillin, erythromycin,
clindamycin, and vancomycin with silver nanoparticles
leads to an increase in antibacterial activity of the
antibiotics against Staphylococcus aureus and
Escherichia coli. This finding suggests that combining
antibiotics with silver nanoparticles increases
antibacterial properties of antibiotics (Shahverdi et al.
2007). In addition, according to Patil and coworkers,
chloramphenicol loaded with nanoparticles showed
substantially enhanced activity against Salmonella
typhi (Patil et al. 2009).
Silver and wound care
Chronic wounds are more likely to be colonized by
normal bacterial microflora such as Staphylococcus
aureus and Streptococcus epidermidis that easily
become cause of opportunistic infection. Silver
containing material could be used to reduce risks and
duration of infections associated with opportunistic
microorganisms.
Castellano et al (2007) reported using eight
commercially available silver-containing dressings
Acticoat ® 7, Acticoat ® Moisture Control, Acticoat ®
Absordent, Silvercel™, Aquacel®, Coutreet®F, Urgotol®
SSD, and Actisorb®. Dressings were tested in vitro for
antimicrobial effectiveness against Escherichia coli
(ATCC 25922), Pseudomonas aeruginosa (ATCC
27853), Streptococcus faecalis (ATCC 29212) and
Staphylococcus aureus (ATCC 29213). Zone of
bacterial inhibition was measured after 24, 48, and 72
hours. Silver-containing dressings were also compared
to efficacy of antimicrobial creams and topical silver
containing antimicrobial gel Silvasorb. Results of this
study suggested that all silver dressings displayed
antimicrobial activity; however, their bactericidal and
bacetriostatic properties were secondary to commonly
used topical antimicrobial agents such as Sulfamylor®
and Gentamicin Sulfate Cream 0.1%.
Ballard and McGregor (2002) described using
silver hydropolymer dressing Avance and Avance A
for open exuding chronic wounds. In the clinical trials
on three patients over a 4-week period Avance
demonstrated many of the characteristics of the ideal
dressing. It had ability to absorb exudate, had
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antimicrobial effect and was easy to use. Silver-
containing hydropolymer dressing Avance not only
facilitated healing of the wound, but also enhanced
quality of life by reducing pain.
Stephen-Haynes and Toner (2007) emphasized
importance of accurate wound assessment and holistic
choice of the silver-containing material for facilitation
of wound healing and wound healing success. Multi-
laminate high density polyethylene dressing containing
nano-crystalline silver Acticoat/Acticoat 7
demonstrated effectiveness in healing of pressure
ulcers, venous ulcers and diabetic ulcers. Actisorb
Silver 220 containing hydrocolloid fibers with silver
was effective against heavy odorous and infected
chronic wounds and ulcers. Hydroalginate with silver
Silvercel was effective against MRSA.
Benbow (2005) described improvement in wound
healing using SILVERHEALING wound pad
containing metallic silver under a polyethylene net
from which silver ions are released when it comes into
contact with exudates. Reportedly, the effect of this
material that has been tested against Staphylococcus
aureus, Escherichia coli, Pseudomonas aeruginosa
and Candida albicans is immediate, inhibitive, and
hypoallergenic.
Jain et al (2009) concluded that silver
nanoparticles could have successful therapeutic use as
a part of the antimicrobial gel for topical use. A
standard antimicrobial sensitivity tests carried out in
Muller-Hinton agar plates were used to evaluate the
antimicrobial activity of the silver nanoparticles
containing gel against bacterial cultures of Escherichia
coli (ATCC 117), Pseudomonas aeruginosa (ATCC
9027), Staphylococcus aureus (ATCC 6538), and
Streptococcus epidermidis (ATCC 12228). Gram-
negative bacteria were killed more effectively (3 log
decrease in 5-9 h) than Gram-positive bacteria (3 log
decrease in 12 h). Gel also exhibited good antifungal
activity (50% inhibition at 75 µg/mL with antifungal
index 55.5% against Aspergillus niger and MIC of 25
µg/mL against Candida albicans). Acute dermal
toxicity studies on gel formulation (S-gel) in Sprague-
Dawley rats showed complete safety for topical
application.
Silver in tumor treatment
Maaskant et al (2009) examined the effectiveness
of chlorhexidine-silver sulfadiazine impregnated
central venous catheters (CVCs) in patients that
received high-dose chemotherapy followed by
peripheral stem cell transplantation. Patients were
treated for different diagnoses including breast cancer,
Non-Hodgkin lymphoma, testicular cancer, Hodgkin’s
disease, Kahler’s diseases, Ewing sarcoma, and other
cancers. Study evaluated 139 patients of whom 69
were provided with impregnated CVCs and 70 patients
with non-impregnated CVCs. The median number of
day a CVC has been used was 16 days in impregnated
group and 18 days in non-impregnated group. Less
catheter colonization was found in the patients with
chlorhexidine-silver sulfadiazine CVCs (RR 0.63, 95%
CI 0.41-0.96; P=0.03). These results were clinically
significant, because colonized CVCs could be a source
of systemic infections. Catheter-related blood stream
infections were also less frequent, but the results did
not meet statistical significance (RR 0.15, 95% CI
0.02-1.15; P=0.06).
Silver nanoparticles have demonstrated inhibition
of the formation of new blood vessels (angiogenesis) in
mice with tumors, possibly due to inactivation of PI3K
signaling pathways. Because angiogenesis is an
important part of normal and pathological growth, this
research is a significant finding for future treatment of
the malignant, ocular, and inflammatory diseases
(Gurunathan et al. 2009).
Silver in fabrics
Use of silver-containing nanoparticles in fabrics
was studied by several scientists. The goal of the study
was to examine the antimicrobial activity in cotton
fabrics loaded with colloidal silver nanoparticles. Also
studied were the antimicrobial affects of silver
deposited onto fabric surfaces against Escherichia coli,
Staphylococcus aureus, and the fungus Candida
albicans. Cotton fabrics loaded with silver
nanoparticles exhibited good antimicrobial activity
(Ilic et al. 2009).
Textile fibers and fabrics have a wide variety of
biomedical applications. According to Russo and
Maffezzoli (2009), there are not too many fabrics with
a good degree of biocompatibility, resistance to
autoclaving, and antibacterial properties. To fill this
void, the silver-coated fibers were developed and
demonstrated good coating stability together with
antimicrobial efficacy (Russo and Maffezzoli 2009).
Hipler et al (2005) presented a study that was
intended to test whether silver-covered seaweed-based
fibers Sea Cell® Active exert antibacterial and
antifungal properties. Colonies of pure culture of
Staphylococcus aureus (ATCC 22926) and Escherichia
coli (ATCC 35218) were inoculated in 5 mL Mueller-
Hinton broth and incubated at 37 °C until the turbidity
of suspension was equal to that of 0.5 McFarland. Sea
Cell® Active was then placed in the center of Muller-
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Hinton agar plates that had been inoculated with test
bacteria and incubated at 37°C for 24 h. Fibers
demonstrated excellent antibacterial properties with
highest activity with Sea Cell® Active fibers with
100% of the active silver load. Sea Cell® Active also
demonstrated reduction of the cell proliferation of the
Candida species (DSM 11225, ATCC 1169, ATCC
6258) down to 10-20% compared with control.
Silver and MRSA
An article in Medical Technology and Devices
Week reported on the potential use of the silver in
preventing the spread of bacterial strains, including
methicillin-resistant Staphylococcus aureus (MRSA).
It described the capability of silver to kill strains of
bacteria that were resistant to current treatments using
antibiotics (Ford et al 2007).
O’Hanlon and Enright (2008) evaluated the
antistaphyloccoccal activity of commercially available
silver containing textile treatment Clineweave® (CW).
Testing included 49 meticillin-resistant genetically
diverse Staphylococcus aureus strains (MRSA)
Antimicrobial activity of CW-treated polyester was
compared to three other commercially available silver-
containing antimicrobial fabrics. In this study only
CW-treated fabric demonstrated any significant
antibacterial activity and reduction of bacterial
numbers within 1 h. Time-kill study of liquid CW in
culture showed 2 log reduction of MRSA within 30
min and 3 log reduction of MRSA within 240 min.
Silver containing textile Clineweave® proved to be
biocidal and useful for reduction of MRSA burden.
Other areas of silver use
Silver-containing compounds have reportedly been
used in material that is used to make binders, markers
and staplers. In Europe antibacterial silver-based
polymers include hospital equipment, medical
packaging, and door handles. Silver based
antimicrobial Makrolon polycarbonate is used in
medical devices like intravenous (IV) systems,
urological devices, and housing for diagnostic and
hospital equipment (Markarian 2009).
Samsung Electronics manufactures new appliances
that use a silver-based antibacterial material termed
“silver nano health systems” (SNHS). Samsung
washing machines contain nano silver particles
coating, refrigerators that use silver trays and that are
coated with silver water-filters, tubes, and air
conditioner surfaces. LG Electronics produces
refrigerators with a silver-containing coating in the
internal food storage compartment.
Jo and colleagues examined the use of silver in the
control of plant diseases caused by pathogenic fungi
Bipolaris Sorokiniana and Magnaporthe grisea.
Results indicated that silver ions and nanoparticles
affected disease progress and spore formation in plant
pathogenic fungi, reducing the progress of the disease
(Jo et al. 2009).
What about toxicity?
In view of silver’s potential toxicity, extensive and
in depth research is needed.
Despite the opinion that there is no silver
accumulation in tissue after topical application,
autopsy study of two patients treated for 1 and 6 month
respectively for burns with 0.5% AgNO3, reveled
significant silver deposition in multiple organs.
Autopsy study on a burned child treated with silver
sulfadiazine cream (AgSD) for 3 months showed silver
deposition in liver and kidney with concentration of the
silver in liver tissue 1600 times that of normal liver
specimen (Fuller 2009).
Coombs et al (1992) in a study of 22 patients with
burns treated with AgSD demonstrated rise in serum
silver levels up to 20 times the normal level within 6
hours after the initial application. Thus, silver
deposition in the tissue could occur whenever serum
silver levels rises and remains above normal.
The most common condition described in the
literature associated with prolong silver exposure is
argyria, which characterized by a blue-gray
discoloration of the skin and total silver concentration
in the blood up to 4-6 g (Lee and Lee 1994, Lansdown
2002, Gosheger et al. 2004).
The latest technologies used for production of
silver-containing compounds appear to be safe and
effective (Lansdown 2002).
Conclusions
Silver has been used for centuries in the form of
silver nitrate, silver sulfadiazine and metallic silver. Its
use has somewhat declined because of the development
and increased use of antibiotics. Today, new
technologies are bringing silver back in the form of
nanoparticles with potential antimicrobial effects.
The results of many studies have demonstrated that
silver nanoparticles inhibit the growth of bacteria
including Staphylococcus aureus, Streptococcus
epidermidis, Enterococcus, Pseudomonas aeruginosa,
Klebsiella pneumonia, Escherichia coli and fungi such
as Candida albicans. Studies suggest that silver
nanoparticles can be used as effective microbial growth
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inhibitors, making silver applicable to diverse medical
devices and antimicrobial control systems.
Despite promising in vitro results, more research is
needed to determine the concentration and size of
silver particles that does not causes toxic silver levels
in serum and/or damage to human organs, but that still
provide bacteriostatic and bacteriosidal effect in
humans.
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